<DOC>
	<DOCNO>NCT01550445</DOCNO>
	<brief_summary>The investigator analyze clinical outcome steroid withdrawal protocol start 3 month kidney transplantation use tacrolimus , Mycophenolate Mofetil ( MMF ) , basiliximab . This study open-label , prospective , control clinical trial single center . Those patient fulfill entry criterion could enter prospective control trial steroid withdrawal three month transplantation .</brief_summary>
	<brief_title>Steroid Withdrawal Immunosuppression After Renal Transplantation</brief_title>
	<detailed_description>Those patient fulfill entry criterion enter prospective control trial steroid withdrawal start three month transplantation . The entry criterion include 1 ) episode clinically treat biopsy confirm acute rejection entry ; 2 ) serum creatinine level equal le 2 mg/mL three separate measurement ; 3 ) proteinuria ( urine protein less 1000 mg/24 hour ; 4 ) tacrolimus trough level &gt; 5 ng/ml without sign nephrotoxicity ; 5 ) agreement follow study protocol . For patient enter protocol , prednisolone would slowly withdrawn 2.5 mg every two week 8 week enter protocol ( 5 month post-transplantation ) . The patient visit every week , closely monitor symptom sign , blood cell count , chemistry , urinalysis .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>Patients age 13 year receive primary kidney transplant Subject use CNI ± purine synthesis inhibitor + steroid without change within past 3 month ( except dosage ) serum creatinine &lt; 2 mg/dL variation serum creatinine &lt; 30 % past 3 month Proteinuria ≤ 1g quantify 24 hour urine spot urine protein/creatinine ratio &lt; 1.0 Subjects agree write informed consent Subjects receive combined nonrenal transplantation . Subject receive retransplantation Deceased donor without heartbeat Patients hypersensitivity Mycophenolate sodium , Mycophenolate acid Mycophenolate Mofetil excipients . Patient HGPRT ( Hypoxanthin eguanine phosphoribosyltransferase ) LeschNyhan syndrome kelleySeegmiller syndrome . HLAidentical living relate donor ABO blood group incompatible HIV , HBsAg , HCV Ab test ( + ) Abnormal liver function test ( AST ALT total bilirubin &gt; upper normal limit x3 ) ANC &lt; 1,500/μL WBC &lt; 2,500/μL platelet &lt; 750,000/μL Women either pregnant , lactating , plan become pregnant next 12 month . Subjects history cancer , except successfully treat , localize nonmelanocytic skin cancer Subjects clinically significant infection within past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Steroid withdrawal , Kidney transplantation</keyword>
</DOC>